Loading
NemaLife
NemaLife is a TechBio company that combines C. elegans nematodes, microfluidic organism-on-chip devices and AI-driven imaging to run fast in vivo safety and efficacy screening of bioactive ingredients. It sells preclinical screening services and multi-ingredient formulation work to ingredient suppliers, consumer brands and pharma/biotech clients. It is also starting internal discovery programs to create bioactive assets it can commercialize. The company is privately held and funded largely by NIH grants (NCCIH, NIDA, NIA), including a $300K NCCIH grant in 2024, plus an investment from Motif FoodWorks. Reported total funding is about $0.6M–$2.3M, depending on the source.
Funding
Every round, secondary, debt facility or acquisition involving NemaLife that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—